Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Cardiovascular, Orthopedic, Ophthalmology), By Application (Wound Healing, Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2022 - 2030

Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Cardiovascular, Orthopedic, Ophthalmology), By Application (Wound Healing, Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2022 - 2030

Medical Biomimetics Market Growth & Trends

The global medical biomimetics market size is expected to reach USD 52.2 billion by 2030, registering a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth. For instance, in April 2021, curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful. As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Numerous companies in the medical biomimetics market are expanding their products in emerging markets. For instance, a most important new development, in November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.

The COVID-19 pandemic is anticipated to negatively impact the medical biomimetics market growth. The COVID-19 pandemic had a considerable effect on the number of patients looking for dental treatments. The overall reduction in the number of patients treated in the Hospitals in Jordan was about 90.4% (17,591 to 1689). As a result, the usage of these technologies was less during the COVID-19 pandemic.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics market.

On the other hand, a stringent regulatory framework hinders the medical biomimetics industry's growth. Regarding the ever-increasing and widespread applications of biomimetic biomaterials in numerous medical fields, their precise assessment is of great significance. Although each biomaterial undergoes thorough premarket evaluation, the regulatory organizations receive a significant number of adverse event and complications reports each year. Moreover, biomaterials are integrated into biological systems, hence, they must fulfill all scientific requirements such as high biocompatibility, sufficiently long shelf-life, and accommodating biological interactions.

Medical Biomimetics Market Report Highlights

  • By type, the cardiovascular segment held the largest share of the medical biomimetics market. This is attributed to the increasing research activities and rising cases of cardiovascular diseases which in turn is likely to increase the adoption of biomimetics and anticipate the medical biomimetics market growth
  • The wound healing segment is expected to grow exponentially over the forecast period. The demand for wound healing and wound care products is growing owing to the escalating number of surgical cases and the increasing prevalence of chronic diseases globally
  • The drug delivery segment of the medical biomimetics market is anticipated to grow at the fastest rate due to crucial developments in nanotechnology that have facilitated efficient and accurate non-carrier drug delivery using biomimetics based devices. Adequate funding and advancements in research and development will boost the medical biomimetics market growth
  • North America dominated the global medical biomimetics market in 2021 due to the high R&D investment, development of novel products, and strong funding from the government in the region
  • The Asia Pacific is expected to grow significantly in the future owing to the expansion of business by key market players along with the increasing prevalence of chronic disorders
  • A few of the key medical biomimetics market players include Otsuka Medical Devices Group, Stryker, Abbott, AVINENT Science and Technology, SynTouch Inc, Osteopore International Pte Ltd, and others
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Technology
1.1.4. Delivery Site
1.1.5. Usability
1.1.6. Application
1.1.7. End-use
1.1.8. Regional scope
1.1.9. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1.1. Commodity flow analysis (Model 1)
1.6.1.2. Approach 1: Commodity flow approach
1.6.1.3. Volume price analysis (Model 2)
1.6.1.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2 Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. Technology outlook
2.2.4. Delivery site outlook
2.2.5. Usability outlook
2.2.6. Application outlook
2.2.7. End-use outlook
2.2.8. Regional outlook
2.3. Competitive Insights
Chapter 3 Needle-free Injectors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing cases of needle-stick injures
3.4.2. Market restraint analysis
3.4.2.1. Lack of awareness in developing and underdeveloped economies
3.4.2.2. Stringent regulations
3.5. Needle-free Injectors Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier product
3.5.1.2. Buyer product
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4 Needle-free Injectors: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Fillable
4.1.2. Prefilled
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Needle-free Injectors Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Fillable
4.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
4.5.2. Prefilled
4.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 5 Needle-free Injectors: Usability Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Disposable
5.1.2. Reusable
5.2. Usability Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Needle-free Injectors Market by Usability Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Disposable
5.5.1.1. Market estimates and forecast 2018 to 2030, (USD million)
5.5.2. Reusable
5.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 6 Needle-free Injectors: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Vaccine Delivery
6.1.2. Insulin Delivery
6.1.3. Pain Management
6.1.4. Others
6.2. Application Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Needle-free Injectors Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Vaccine delivery
6.5.1.1. Market estimates and forecast 2018 to 2030, (USD million)
6.5.2. Insulin delivery
6.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
6.5.3. Pain management
6.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
6.5.4. Others
6.5.4.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 7 Needle-free Injectors: Technology Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Spring-based needle-free injectors
7.1.2. Gas-powered needle-free injectors
7.1.3. Laser-powered needle-free injectors
7.1.4. Vibration-based needle-free injectors
7.2. Technology Market Share, 2022 & 2030
7.3. Segment Dashboard
7.4. Global Needle-free Injectors Market by Technology Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Spring-based needle-free injectors
7.5.1.1. Market estimates and forecast 2018 to 2030, (USD million)
7.5.2. Gas-powered needle-free injectors
7.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
7.5.3. Laser-powered needle-free injectors
7.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
7.5.4. Vibration-based needle-free injectors
7.5.4.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 8 Needle-free Injectors: Type Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Powder-based needle free injectors
8.1.2. Liquid-based needle free injectors
8.1.3. Projectile/depot-based needle free injectors
8.2. Type Market Share, 2022 & 2030
8.3. Segment Dashboard
8.4. Global Needle-free Injectors Market by Type Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Powder-based needle free injectors
8.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
8.5.2. Liquid-based needle free injectors
8.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
8.5.3. Projectile/depot-based needle free injectors
8.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 9 Needle-free Injectors: Delivery Site Estimates & Trend Analysis
9.1. Definitions and Scope
9.1.1. Subcutaneous
9.1.2. Intramuscular
9.1.3. Intradermal
9.2. Delivery Site Market Share, 2022 & 2030
9.3. Segment Dashboard
9.4. Global Needle-free Injectors Market by Delivery Site Outlook
9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.5.1. Subcutaneous
9.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
9.5.2. Intramuscular
9.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
9.5.3. Intradermal
9.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 10 Needle-free Injectors: End-use Estimates & Trend Analysis
10.1. Definitions and Scope
10.1.1. Hospitals & Clinics
10.1.2. Home Care Settings
10.1.3. Research Laboratories
10.2. End-use Market Share, 2022 & 2030
10.3. Segment Dashboard
10.4. Global Needle-free Injectors Market by End-use Outlook
10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
10.5.1. Hospitals & clinics
10.5.1.1. Market estimates and forecast 2018 to 2030, (USD Million)
10.5.2. Home care settings
10.5.2.1. Market estimates and forecast 2018 to 2030, (USD Million)
10.5.3. Research laboratories
10.5.3.1. Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 11 Needle-free Injectors Market: Regional Estimates & Trend Analysis
11.1. Regional market share analysis, 2022 & 2030
11.2. Regional Market Dashboard
11.3. Global Regional Market Snapshot
11.4. Regional Market Share and Leading Players, 2022
11.4.1. North America
11.4.2. Europe
11.4.3. Asia Pacific
11.4.4. Latin America
11.4.5. Middle East and Africa
11.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
11.5.1. North America
11.5.2. Europe
11.5.3. Asia Pacific
11.5.4. Latin America
11.5.5. Middle East and Africa
11.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
11.7. North America
11.7.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.7.2. U.S.
11.7.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.7.3. Canada
11.7.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.8. Europe
11.8.1. U.K.
11.8.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.8.2. Germany
11.8.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.8.3. France
11.8.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.8.4. Italy
11.8.4.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.8.5. Spain
11.8.5.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.9. Asia Pacific
11.9.1. China
11.9.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.9.2. Japan
11.9.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.9.3. India
11.9.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.9.4. South Korea
11.9.4.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.9.5. Australia
11.9.5.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.10. Latin America
11.10.1. Brazil
11.10.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.10.2. Mexico
11.10.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.10.3. Argentina
11.10.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.10.4. Colombia
11.10.4.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.11. MEA
11.11.1. Saudi Arabia
11.11.1.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.11.2. South Africa
11.11.2.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
11.11.3. UAE
11.11.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
Chapter 12 Competitive Landscape
12.1. Recent Developments & Impact Analysis, By Key Market Participants
12.2. Company/Competition Categorization
12.2.1. Innovators
12.3. Vendor Landscape
12.3.1. List of key distributors and channel partners
12.3.2. Key customers
12.3.3. Key company market share analysis, 2022
12.3.4. PharmaJet.
12.3.4.1. Company overview
12.3.4.2. Financial performance
12.3.4.3. Product benchmarking
12.3.4.4. Strategic initiatives
12.3.5. Crossject
12.3.5.1. Company overview
12.3.5.2. Financial performance
12.3.5.3. Product benchmarking
12.3.5.4. Strategic initiatives
12.3.6. Portal Instruments
12.3.6.1. Company overview
12.3.6.2. Financial performance
12.3.6.3. Product benchmarking
12.3.6.4. Strategic initiatives
12.3.7. NuGen Medical Devices
12.3.7.1. Company overview
12.3.7.2. Financial performance
12.3.7.3. Product benchmarking
12.3.7.4. Strategic initiatives
12.3.8. Inovio Pharmaceuticals
12.3.8.1. Company overview
12.3.8.2. Financial performance
12.3.8.3. Product benchmarking
12.3.8.4. Strategic initiatives
12.3.9. Antares Pharma, Inc
12.3.9.1. Company overview
12.3.9.2. Financial performance
12.3.9.3. Product benchmarking
12.3.9.4. Strategic initiatives
12.3.10. Aijex Pharma International Inc.
12.3.10.1. Company overview
12.3.10.2. Financial performance
12.3.10.3. Product benchmarking
12.3.10.4. Strategic initiatives
12.3.11. Ferring B.V.
12.3.11.1. Company overview
12.3.11.2. Financial performance
12.3.11.3. Product benchmarking
12.3.11.4. Strategic initiatives
12.3.12. Penjet Corporation
12.3.12.1. Company overview
12.3.12.2. Financial performance
12.3.12.3. Product benchmarking
12.3.12.4. Strategic initiatives
12.3.13. Medical International Technology Inc.
12.3.13.1. Company overview
12.3.13.2. Financial performance
12.3.13.3. Product benchmarking
12.3.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings